RISK STRATIFICATION WITH PRE-TREATMENT METABOLITE RISK SCORE FOR CARFILZOMIB-RELATED CARDIOTOXICITY IN MULTIPLE MYELOMA PATIENTS.

被引：0
|
作者：
Nguyen, T. [1 ]
Tantawy, M. [1 ]
Zhou, Y. [1 ]
Rubinstein, S. [2 ]
Garrett, T. [1 ]
Baz, R. [3 ]
Fradley, M. [4 ]
Lu, Q. [1 ]
Lenihan, D. [5 ]
Cornell, R. [6 ]
Gong, Y. [1 ]
机构：
[1] Univ Florida, Gainesville, FL USA
[2] Univ N Carolina, Chapel Hill, NC 27515 USA
[3] H Lee Moffitt Canc Ctr Res Inst, Tampa, FL USA
[4] Univ Penn, Philadelphia, PA 19104 USA
[5] Washington Univ, St Louis, MO 63110 USA
[6] Abb Vie, Chicago, IL USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2022年 / 111卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PT-014
引用
收藏
页码：S66 / S66
页数：1
相关论文
共 50 条
  • [41] Treatment patterns and outcomes according to cytogenetic risk stratification in patients with multiple myeloma: a real-world analysis
    Atrash, Shebli
    Flahavan, Evelyn M.
    Xu, Tao
    Ma, Esprit
    Karve, Sudeep
    Hong, Wan-Jen
    Jirau-Lucca, Gilbert
    Nixon, Michael
    Ailawadhi, Sikander
    BLOOD CANCER JOURNAL, 2022, 12 (03)
  • [42] Pre-Treatment Risk Assessment for Elderly Patients with Acute Myeloid Leukemia
    Arevalo-Zambrano, Monica
    Abello-Polo, Virginia
    Omana-Orduz, Olga-Paola
    Villamizar-Gomez, Licet
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 : S205 - S206
  • [43] Cardiotoxicity risk with bortezomib versus lenalidomide for treatment of multiple myeloma: A propensity matched study of 1,790 patients
    Reneau, John C.
    Asante, Dennis
    van Houten, Holly
    Sangaralingham, Lindsey R.
    Buadi, Francis K.
    Lerman, Amir
    Herrmann, Joerg
    AMERICAN JOURNAL OF HEMATOLOGY, 2017, 92 (02) : E15 - E17
  • [44] MIRNA-125A ASSOCIATION WITH CARFILZOMIB-RELATED CARDIOVASCULAR ADVERSE EVENTS IN MULTIPLE MYELOMA PATIENTS: PROSPECTIVE OBSERVATION OF CARDIAC SAFETY WITH PROTEASOME INHIBITOR (PROTECT) STUDY
    Tantawy, M.
    Langaee, T.
    Wang, D.
    Rubinstein, S.
    Cornell, R.
    Lenihan, D.
    Fradley, M.
    Gong, Y.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2023, 113 : S60 - S60
  • [45] A miRNA Risk Score for the Prediction of Response to Lenalidomide in Multiple Myeloma (MM) Patients
    Neri, Paola
    Belch, Andrew R.
    Johnson, Jordan
    Gratton, Kathy J.
    Ren, Li
    Duggan, Peter
    Mansoor, Adnan
    Stewart, Douglas A.
    Bahlis, Nizar
    BLOOD, 2011, 118 (21) : 451 - 451
  • [46] Carfilzomib significantly improves the progression-free survival of high-risk patients in multiple myeloma
    Avet-Loiseau, Herve
    Fonseca, Rafael
    Siegel, David
    Dimopoulos, Meletios A.
    Spicka, Ivan
    Masszi, Tamas
    Hajek, Roman
    Rosinol, Laura
    Goranova-Marinova, Vesselina
    Mihaylov, Georgi
    Maisnar, Vladimir
    Mateos, Maria-Victoria
    Wang, Michael
    Niesvizky, Ruben
    Oriol, Albert
    Jakubowiak, Andrzej
    Minarik, Jiri
    Palumbo, Antonio
    Bensinger, William
    Kukreti, Vishal
    Ben-Yehuda, Dina
    Stewart, A. Keith
    Obreja, Mihaela
    Moreau, Philippe
    BLOOD, 2016, 128 (09) : 1174 - 1180
  • [47] IMPACT OF TREATMENT WITH BORTEZOMIB ON THE RISK OF INFECTION IN PATIENTS WITH MULTIPLE MYELOMA
    Sofia, Costa
    Sebastian, Ortiz
    Karla, Javier
    Carolina, Villegas
    Pedro, Perez
    Teresa, Orero M.
    Maria, Lopez
    Monica, Roig
    Felix, Carbonell
    Irene, Luna
    Rosa, Collado
    Mariano, Linares
    HAEMATOLOGICA, 2016, 101 : 98 - 99
  • [48] Multiple Myeloma, Venous Thromboembolism, and Treatment-Related Risk of Thrombosis
    Zamagni, Elena
    Brioli, Annamaria
    Tacchetti, Paola
    Zannetti, Beatrice
    Pantani, Lucia
    Cavo, Michele
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2011, 37 (03): : 209 - 219
  • [49] The Impact of Dynamic Assessment of Risk Stratification at the Time of Disease Progression in Patients with Multiple Myeloma
    Fan, Huishou
    Yan, Wenqiang
    Xu, Jingyu
    Du, Chenxing
    Sui, Weiwei
    Deng, Shuhui
    Zou, Dehui
    Qiu, Lugui
    An, Gang
    BLOOD, 2022, 140 : 4371 - 4373
  • [50] GCRS: A hybrid graph convolutional network for risk stratification in multiple myeloma cancer patients
    Sagar, Dikshant
    Aggarwal, Priya
    Farswan, Akanksha
    Gupta, Ritu
    Gupta, Anubha
    COMPUTERS IN BIOLOGY AND MEDICINE, 2022, 149
12345